| ATC code A: Alimentary tract and metabolism |
|---|
|
| Other ATC codes |
|
|
ATC code A02 Drugs for acid related disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A02 is part of the anatomical group AAlimentary tract and metabolism.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
|
| |
|---|---|
| Magnesium (increases motility) |
|
| Aluminium (decreases motility) |
|
| Calcium |
|
| Sodium |
|
| Combinations and complexes of aluminium, calcium and magnesium |
|
|
| |
|---|---|
| H2 antagonists ("-tidine") |
|
| Prostaglandins (E)/ analogues ("-prost-") |
|
| Proton-pump inhibitors ("-prazole") |
|
| Potassium-competitive acid blockers ("-prazan") |
|
| Others |
|
| Combinations |
|
| |
| |
